Upgrades:
J.B. Hunt Transport Services (NASDAQ:JBHT) was upgraded by research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research note issued to investors on Monday, Marketbeat.com reports. The firm currently has a $220.00 target price on the transportation company’s stock, up from their prior target price of $200.00. BMO Capital Markets’ target price would suggest a potential upside of 14.00% from the company’s previous close.
A number of other research analysts have also issued reports on JBHT. Morgan Stanley lowered their target price on shares of J.B. Hunt Transport Services from $169.00 to $165.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 18th. Raymond James decreased their price target on shares of J.B. Hunt Transport Services from $205.00 to $200.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 18th. Stephens restated an “overweight” rating and issued a $210.00 price target on shares of J.B. Hunt Transport Services in a research report on Wednesday, October 18th. Benchmark restated a “buy” rating and issued a $200.00 price target on shares of J.B. Hunt Transport Services in a research report on Wednesday, October 4th. Finally, UBS Group upgraded shares of J.B. Hunt Transport Services from a “sell” rating to a “neutral” rating and set a $205.00 price target on the stock in a research report on Thursday, December 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have given a buy rating to the company. According to MarketBeat, J.B. Hunt Transport Services presently has an average rating of “Hold” and an average target price of $199.79. Read more …
Evercore ISI upgraded shares of HP (NYSE:HPQ) from an in-line rating to an outperform rating in a report released on Monday, Marketbeat reports. They currently have $40.00 target price on the computer maker’s stock, up from their prior target price of $33.00.
Other equities research analysts also recently issued research reports about the company. JPMorgan Chase & Co. lowered their price objective on HP from $40.00 to $39.00 and set an overweight rating for the company in a research report on Wednesday, August 30th. Morgan Stanley lifted their price objective on HP from $30.00 to $31.00 and gave the company an equal weight rating in a research report on Wednesday, October 11th. Deutsche Bank Aktiengesellschaft lowered their price objective on HP from $32.00 to $30.00 and set a hold rating for the company in a research report on Wednesday, August 30th. StockNews.com raised HP from a buy rating to a strong-buy rating in a research report on Friday, November 17th. Finally, Bank of America upgraded HP from an underperform rating to a buy rating and lifted their target price for the company from $25.00 to $33.00 in a report on Tuesday, October 3rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Moderate Buy and a consensus target price of $31.50. Read more …
Jefferies Financial Group upgraded shares of Best Buy (NYSE:BBY) from a hold rating to a buy rating in a research report released on Monday, Marketbeat reports. They currently have $89.00 target price on the technology retailer’s stock, up from their prior target price of $69.00.
A number of other equities analysts also recently commented on the company. UBS Group lowered their price objective on Best Buy from $85.00 to $76.00 and set a neutral rating for the company in a research report on Monday, November 13th. Morgan Stanley upped their target price on Best Buy from $75.00 to $80.00 and gave the company an equal weight rating in a report on Thursday, August 31st. Wedbush restated a neutral rating and issued a $70.00 price objective on shares of Best Buy in a research report on Wednesday, November 22nd. DA Davidson increased their target price on Best Buy from $87.00 to $90.00 and gave the stock a buy rating in a research report on Wednesday, August 30th. Finally, Evercore ISI cut their price objective on Best Buy from $75.00 to $70.00 and set an in-line rating on the stock in a report on Wednesday, November 22nd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Hold and an average target price of $76.53. Read more …
Mizuho upgraded shares of Realty Income (NYSE:O) from a neutral rating to a buy rating in a research note issued to investors on Monday, Briefing.com reports. They currently have $58.00 price objective on the real estate investment trust’s stock, up from their prior price objective of $48.00.
O has been the subject of several other research reports. Wells Fargo & Company began coverage on shares of Realty Income in a research report on Wednesday, September 20th. They set an equal weight rating and a $59.00 target price for the company. Citigroup dropped their target price on shares of Realty Income from $65.00 to $61.50 and set a neutral rating for the company in a research report on Tuesday, August 29th. JPMorgan Chase & Co. dropped their target price on shares of Realty Income from $71.00 to $69.00 and set a neutral rating for the company in a research report on Wednesday, August 30th. TheStreet cut shares of Realty Income from a b- rating to a c+ rating in a research report on Wednesday, August 23rd. Finally, Royal Bank of Canada upped their price objective on shares of Realty Income from $56.00 to $57.00 and gave the company an outperform rating in a research report on Wednesday, November 8th. Nine investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of Hold and an average price target of $62.27. Read more …
NIKE (NYSE:NKE) was upgraded by analysts at Citigroup from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Monday, MarketBeat.com reports. The firm presently has a $135.00 target price on the footwear maker's stock, up from their previous target price of $100.00. Citigroup's price objective indicates a potential upside of 16.47% from the company's current price.
Several other brokerages also recently issued reports on NKE. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $139.00 price objective on shares of NIKE in a research report on Tuesday, December 5th. BMO Capital Markets lowered their price target on shares of NIKE from $120.00 to $110.00 and set an "outperform" rating for the company in a report on Friday, September 29th. Evercore ISI initiated coverage on shares of NIKE in a research note on Tuesday, November 7th. They set an "outperform" rating and a $124.00 price target on the stock. Barclays lowered their target price on NIKE from $124.00 to $119.00 and set an "overweight" rating for the company in a research note on Friday, September 29th. Finally, HSBC cut their price target on NIKE from $120.00 to $113.00 and set a "hold" rating on the stock in a research note on Monday, September 18th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and twenty-three have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $123.43. Read more …
The Goldman Sachs Group upgraded shares of AbbVie (NYSE:ABBV) from a neutral rating to a buy rating in a research note issued to investors on Monday, Marketbeat reports. The brokerage currently has $173.00 price target on the stock.
Other analysts have also issued research reports about the company. TheStreet raised AbbVie from a c+ rating to a b rating in a report on Monday, August 28th. Raymond James upped their price objective on AbbVie from $177.00 to $181.00 and gave the company an outperform rating in a research report on Friday, December 1st. StockNews.com started coverage on AbbVie in a research report on Thursday, October 5th. They set a strong-buy rating on the stock. Morgan Stanley upped their price objective on AbbVie from $193.00 to $196.00 and gave the company an overweight rating in a research report on Monday, October 30th. Finally, Deutsche Bank Aktiengesellschaft started coverage on AbbVie in a research report on Thursday, November 9th. They set a hold rating and a $150.00 price objective on the stock. Eight investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and an average price target of $168.24. Read more …
Domino's Pizza (NYSE:DPZ) was upgraded by equities researchers at Benchmark from a "hold" rating to a "buy" rating in a report issued on Monday, Briefing.com reports. The brokerage currently has a $455.00 target price on the restaurant operator's stock. Benchmark's price objective would indicate a potential upside of 15.22% from the company's current price.
A number of other equities analysts have also commented on DPZ. TD Cowen raised their price target on shares of Domino's Pizza from $430.00 to $470.00 and gave the stock an "outperform" rating in a research report on Friday. Stephens raised their target price on shares of Domino's Pizza from $365.00 to $400.00 and gave the stock an "equal weight" rating in a report on Friday. StockNews.com assumed coverage on Domino's Pizza in a research note on Thursday, October 5th. They issued a "hold" rating for the company. Piper Sandler lowered their price objective on Domino's Pizza from $409.00 to $401.00 and set an "overweight" rating on the stock in a research note on Friday, October 13th. Finally, Evercore ISI lifted their price objective on Domino's Pizza from $435.00 to $450.00 and gave the company an "outperform" rating in a report on Friday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $409.93. Read more …
Extra Space Storage (NYSE:EXR) was upgraded by equities research analysts at Wells Fargo & Company from an "underweight" rating to an "overweight" rating in a research note issued on Tuesday, MarketBeat reports. The firm presently has a $155.00 price target on the real estate investment trust's stock, up from their previous price target of $120.00. Wells Fargo & Company's price objective suggests a potential upside of 12.21% from the company's previous close.
Other research analysts have also issued research reports about the company. Truist Financial dropped their target price on Extra Space Storage from $155.00 to $138.00 and set a "hold" rating for the company in a research report on Tuesday, August 29th. Bank of America lowered Extra Space Storage from a "buy" rating to a "neutral" rating and dropped their target price for the company from $155.00 to $119.00 in a research report on Monday, October 30th. TheStreet lowered Extra Space Storage from a "b-" rating to a "c" rating in a research report on Tuesday, November 7th. The Goldman Sachs Group assumed coverage on Extra Space Storage in a research report on Wednesday, September 27th. They set a "buy" rating and a $153.00 target price for the company. Finally, Raymond James dropped their target price on Extra Space Storage from $165.00 to $145.00 and set a "strong-buy" rating for the company in a research report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, six have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $146.27. Read more …
Albemarle (NYSE:ALB) was upgraded by investment analysts at Bank of America from an "underperform" rating to a "neutral" rating in a note issued to investors on Tuesday, FinViz reports. The brokerage presently has a $149.00 price target on the specialty chemicals company's stock, down from their previous price target of $154.00. Bank of America's price target indicates a potential upside of 17.74% from the company's previous close.
A number of other analysts have also recently issued reports on ALB. Wells Fargo & Company reduced their price objective on shares of Albemarle from $260.00 to $210.00 and set an "overweight" rating for the company in a research note on Monday, October 9th. UBS Group downgraded Albemarle from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $253.00 to $140.00 in a research report on Monday, November 6th. Citigroup cut their target price on Albemarle from $265.00 to $215.00 and set a "buy" rating on the stock in a research report on Wednesday, October 4th. TheStreet lowered shares of Albemarle from a "b-" rating to a "c+" rating in a report on Monday, November 6th. Finally, Piper Sandler lowered Albemarle from a "neutral" rating to an "underweight" rating and dropped their target price for the company from $140.00 to $128.00 in a research report on Tuesday, December 5th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $230.32. Read more …
A. O. Smith (NYSE:AOS) was upgraded by Northcoast Research from a "neutral" rating to a "buy" rating in a report issued on Tuesday, Benzinga reports. The firm currently has a $90.00 price target on the industrial products company's stock. Northcoast Research's price target suggests a potential upside of 15.33% from the company's current price.
Several other analysts have also recently weighed in on the stock. Citigroup lifted their price objective on shares of A. O. Smith from $76.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday. StockNews.com assumed coverage on A. O. Smith in a research note on Thursday, October 5th. They issued a "buy" rating for the company. Finally, Stifel Nicolaus reiterated a "hold" rating and set a $80.00 price objective on shares of A. O. Smith in a research note on Tuesday, September 12th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, A. O. Smith presently has an average rating of "Hold" and an average target price of $74.38.
A. O. Smith stock opened at $78.04 on Tuesday. The company has a market capitalization of $11.61 billion, a price-to-earnings ratio of 39.02, a PEG ratio of 2.30 and a beta of 1.25. The company has a current ratio of 1.68, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. A. O. Smith has a 12 month low of $55.41 and a 12 month high of $79.29. The stock's 50 day moving average is $71.85 and its 200-day moving average is $70.98. Read more ...
Humana (NYSE:HUM) was upgraded by equities researchers at Argus from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Tuesday, FinViz reports. The firm currently has a $550.00 price target on the insurance provider's stock. Argus' target price points to a potential upside of 15.38% from the stock's current price.
Several other equities research analysts have also recently weighed in on HUM. Sanford C. Bernstein dropped their target price on Humana from $599.00 to $579.00 in a report on Tuesday, October 10th. Royal Bank of Canada raised their target price on shares of Humana from $594.00 to $599.00 and gave the stock an "outperform" rating in a report on Thursday, November 2nd. Morgan Stanley decreased their target price on shares of Humana from $637.00 to $624.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 30th. StockNews.com raised shares of Humana from a "buy" rating to a "strong-buy" rating in a research report on Friday, November 3rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Humana from $593.00 to $575.00 and set a "neutral" rating on the stock in a research report on Friday, November 17th. Three equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of "Moderate Buy" and an average price target of $588.16. Read more …
Downgrades:
Wolfe Research reiterated their peer perform rating on shares of Parker-Hannifin (NYSE:PH) in a research note released on Monday morning, Marketbeat reports.
A number of other brokerages have also recently issued reports on PH. Stifel Nicolaus reissued a buy rating and set a $500.00 price objective on shares of Parker-Hannifin in a report on Monday, December 4th. StockNews.com started coverage on Parker-Hannifin in a research report on Thursday, October 5th. They issued a buy rating for the company. Bank of America upgraded Parker-Hannifin from a neutral rating to a buy rating and lifted their price objective for the stock from $435.00 to $475.00 in a research report on Thursday, October 5th. Deutsche Bank Aktiengesellschaft upgraded Parker-Hannifin from a hold rating to a buy rating and lifted their price objective for the stock from $462.00 to $506.00 in a research report on Thursday, November 9th. Finally, Wells Fargo & Company lowered their price objective on Parker-Hannifin from $465.00 to $425.00 in a research report on Monday, October 9th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, Parker-Hannifin currently has a consensus rating of Moderate Buy and a consensus target price of $452.86. Read more …
EOG Resources (NYSE:EOG) was downgraded by investment analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a report released on Monday, Briefing.com reports. They currently have a $134.00 target price on the energy exploration company's stock. Morgan Stanley's price objective suggests a potential upside of 12.64% from the stock's current price.
Several other equities analysts have also issued reports on the company. UBS Group lifted their price target on EOG Resources from $164.00 to $165.00 and gave the company a "buy" rating in a research note on Wednesday, October 4th. Mizuho dropped their target price on shares of EOG Resources from $158.00 to $150.00 and set a "buy" rating for the company in a report on Wednesday, November 15th. JPMorgan Chase & Co. downgraded shares of EOG Resources from an "overweight" rating to a "neutral" rating and dropped their price objective for the company from $156.00 to $150.00 in a research note on Wednesday, December 6th. Susquehanna decreased their target price on shares of EOG Resources from $165.00 to $164.00 and set a "positive" rating on the stock in a research note on Wednesday, October 18th. Finally, Truist Financial raised their price objective on EOG Resources from $165.00 to $169.00 and gave the company a "buy" rating in a report on Monday, November 6th. Eight analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, EOG Resources has an average rating of "Moderate Buy" and an average price target of $147.05. Read more …
Lam Research (NASDAQ:LRCX) was downgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a report released on Tuesday, FinViz reports. They currently have a $725.00 price target on the semiconductor company's stock, up from their previous price target of $680.00. Deutsche Bank Aktiengesellschaft's target price would suggest a potential downside of 1.44% from the stock's previous close.
Several other brokerages also recently commented on LRCX. JPMorgan Chase & Co. dropped their target price on Lam Research from $720.00 to $700.00 and set an "overweight" rating on the stock in a report on Thursday, October 19th. StockNews.com initiated coverage on shares of Lam Research in a research report on Thursday, October 5th. They set a "hold" rating for the company. B. Riley upped their target price on shares of Lam Research from $690.00 to $700.00 and gave the company a "neutral" rating in a research note on Thursday, October 19th. Needham & Company LLC raised Lam Research from a "hold" rating to a "buy" rating and set a $800.00 target price on the stock in a report on Friday, October 13th. Finally, Morgan Stanley lowered Lam Research from an "overweight" rating to an "equal weight" rating and set a $720.00 price target on the stock. in a research report on Friday. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $685.75. Read more …
Agilent Technologies (NYSE:A) was downgraded by investment analysts at Bank of America from a "buy" rating to a "neutral" rating in a report released on Tuesday, Marketbeat reports. They currently have a $133.00 price objective on the medical research company's stock, up from their prior price objective of $130.00. Bank of America's target price suggests a potential upside of 3.13% from the company's current price.
A has been the subject of several other research reports. UBS Group downgraded Agilent Technologies from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $163.00 to $125.00 in a research note on Friday, November 17th. TD Cowen upped their price objective on Agilent Technologies from $145.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, August 16th. Credit Suisse Group lowered their price objective on Agilent Technologies from $160.00 to $150.00 and set an "outperform" rating for the company in a research note on Wednesday, August 16th. Jefferies Financial Group lowered their price objective on Agilent Technologies from $150.00 to $146.00 and set a "buy" rating for the company in a research note on Wednesday, August 16th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Agilent Technologies from $155.00 to $150.00 and set an "overweight" rating for the company in a research report on Wednesday, August 16th. One analyst has rated the stock with a sell rating, seven have given a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of "Hold" and a consensus price target of $137.44. Read more …
Walker & Dunlop (NYSE:WD) was downgraded by investment analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating in a research note issued to investors on Wednesday, Briefing.com reports. They presently have a $105.00 target price on the financial services provider's stock, up from their previous target price of $85.00. Keefe, Bruyette & Woods' price target would indicate a potential upside of 8.72% from the stock's previous close.
Other equities analysts have also issued research reports about the company. StockNews.com raised Walker & Dunlop from a "sell" rating to a "hold" rating in a research note on Thursday, November 16th. Wedbush boosted their price objective on Walker & Dunlop from $90.00 to $110.00 and gave the stock an "outperform" rating in a research note on Monday. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, Walker & Dunlop has a consensus rating of "Hold" and an average target price of $107.50.
WD opened at $96.58 on Wednesday. The stock has a market cap of $3.23 billion, a PE ratio of 27.67 and a beta of 1.48. Walker & Dunlop has a 1 year low of $61.06 and a 1 year high of $101.02. The stock's 50 day simple moving average is $76.55 and its 200-day simple moving average is $80.23. Read more …
Johnson & Johnson (NYSE:JNJ) was downgraded by research analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating in a report released on Wednesday, Marketbeat.com reports. They presently have a $163.00 price target on the stock, down from their previous price target of $170.00. Wells Fargo & Company's price target would indicate a potential upside of 5.11% from the company's current price.
A number of other research firms have also weighed in on JNJ. UBS Group raised Johnson & Johnson from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $167.00 to $180.00 in a report on Friday, December 1st. Raymond James decreased their target price on Johnson & Johnson from $179.00 to $172.00 and set an "outperform" rating on the stock in a report on Wednesday, October 18th. HSBC began coverage on Johnson & Johnson in a research report on Wednesday, September 6th. They set a "hold" rating and a $175.00 price objective on the stock. Cantor Fitzgerald reiterated an "overweight" rating and set a $215.00 price objective on shares of Johnson & Johnson in a research report on Friday, November 17th. Finally, Barclays increased their price objective on Johnson & Johnson from $158.00 to $162.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 12th. Eight equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Johnson & Johnson presently has a consensus rating of "Moderate Buy" and an average target price of $168.75. Read more …
Church & Dwight (NYSE:CHD) was downgraded by equities researchers at Citigroup from a "neutral" rating to a "sell" rating in a research note issued on Wednesday, Marketbeat reports. They presently have a $90.00 price target on the stock. Citigroup's target price points to a potential downside of 4.72% from the stock's previous close.
CHD has been the topic of several other research reports. Raymond James upgraded shares of Church & Dwight from an "underperform" rating to a "market perform" rating in a report on Monday, October 23rd. JPMorgan Chase & Co. boosted their price target on shares of Church & Dwight from $91.00 to $93.00 and gave the company an "underweight" rating in a research report on Thursday, October 12th. Truist Financial upgraded shares of Church & Dwight from a "hold" rating to a "buy" rating and upped their target price for the stock from $95.00 to $105.00 in a research report on Monday, August 28th. The Goldman Sachs Group reduced their target price on shares of Church & Dwight from $100.00 to $89.00 and set a "neutral" rating on the stock in a research report on Monday, November 6th. Finally, Jefferies Financial Group initiated coverage on shares of Church & Dwight in a report on Monday, November 13th. They issued a "hold" rating and a $99.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $95.00. Read more …
Citigroup cut shares of LyondellBasell Industries (NYSE:LYB) from a buy rating to a neutral rating in a research note published on Wednesday morning, MarketBeat.com reports. They currently have $98.00 target price on the specialty chemicals company’s stock, down from their previous target price of $105.00.
Other equities research analysts also recently issued research reports about the company. Piper Sandler decreased their price objective on LyondellBasell Industries from $112.00 to $108.00 and set an overweight rating for the company in a report on Wednesday, October 11th. Royal Bank of Canada decreased their price target on LyondellBasell Industries from $116.00 to $108.00 and set an outperform rating for the company in a report on Monday. KeyCorp upgraded LyondellBasell Industries from an underweight rating to a sector weight rating in a report on Tuesday, October 3rd. Bank of America upgraded LyondellBasell Industries from an underperform rating to a neutral rating and upped their price target for the stock from $99.00 to $107.00 in a report on Wednesday, October 18th. Finally, StockNews.com assumed coverage on LyondellBasell Industries in a report on Thursday, October 5th. They set a buy rating for the company. Nine investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, LyondellBasell Industries currently has a consensus rating of Hold and an average price target of $101.00. Read more …
Agree Realty (NYSE:ADC) was downgraded by research analysts at BNP Paribas from an "outperform" rating to a "neutral" rating in a research report issued on Wednesday, Marketbeat.com reports. They presently have a $64.00 target price on the real estate investment trust's stock. BNP Paribas' price objective suggests a potential upside of 7.78% from the stock's current price.
A number of other equities research analysts have also weighed in on the company. StockNews.com raised Agree Realty from a "sell" rating to a "hold" rating in a research report on Friday, October 13th. TheStreet downgraded Agree Realty from a "b-" rating to a "c+" rating in a report on Monday, September 11th. Royal Bank of Canada cut their price target on Agree Realty from $74.00 to $63.00 and set an "outperform" rating on the stock in a report on Thursday, October 26th. Wells Fargo & Company began coverage on Agree Realty in a report on Wednesday, September 20th. They issued an "overweight" rating and a $70.00 price target on the stock. Finally, Truist Financial cut their price target on Agree Realty from $74.00 to $62.00 and set a "buy" rating on the stock in a report on Monday, November 27th. Five research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $67.69. Read more …
Archive of Upgrades and Downgrades
Comments
Post a Comment